Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

GNF 5

Name GNF 5
Supplier R&D Systems
Catalog 4908
Prices $225.00, $925.00
Sizes 10 mg, 50 mg
Cas Number 778277-15-9
Chemical Name N-(2-Hydroxyethyl)-3-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide
Formula C20H17F3N4O3
Molecular Weight 418.37
Purity >98%
Supplier Page Shop

Product References

Allosteric interactions between the myristate- and ATP-site of the Abl kinase. - Allosteric interactions between the myristate- and ATP-site of the Abl kinase.

Iacob RE, Zhang J, Gray NS, Engen JR. PLoS One. 2011 Jan 10;6(1):e15929.

Expanding the diversity of allosteric bcr-abl inhibitors. - Expanding the diversity of allosteric bcr-abl inhibitors.

Deng X, Okram B, Ding Q, Zhang J, Choi Y, Adrian FJ, Wojciechowski A, Zhang G, Che J, Bursulaya B, Cowan-Jacob SW, Rummel G, Sim T, Gray NS. J Med Chem. 2010 Oct 14;53(19):6934-46.

Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. - Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors.

Zhang J, Adrian FJ, Jahnke W, Cowan-Jacob SW, Li AG, Iacob RE, Sim T, Powers J, Dierks C, Sun F, Guo GR, Ding Q, Okram B, Choi Y, Wojciechowski A, Deng X, Liu G, Fendrich G, Strauss A, Vajpai N, Grzesiek S, Tuntland T, Liu Y, Bursulaya B, Azam M, Manley PW, Engen JR, Daley GQ, Warmuth M, Gray NS. Nature. 2010 Jan 28;463(7280):501-6.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved